Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08189 TEDA BIOMEDICAL
RT Nominal down0.350 -0.010 (-2.778%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others70,605-4.104%73,62778,76279,57358,561
Land & other Lease Assets39,045-0.672%39,30953,28659,23767,781
Intangible Assets0--012,074372,456
Interests in Asso. & JCEs0--0003,948
Other Non-current Assets0--0000

109,650-2.910%112,936144,122138,847132,746
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories80,257-11.276%90,45774,00475,22191,642
Trade Receivables9,80911.764%8,77731,86732,08243,892
Cash & Bank Balances18,200206.684%5,9346,85626,43913,532
Other Current Assets92,13730.840%70,42080,34770,058111,106
Assets Held for Sale0--14,75404,9480

200,4035.286%190,342193,075208,749260,173
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables10,359-35.687%16,10720,72329,53343,768
S-T Debt & Leases78,66924.354%63,26267,37245,13111,191
Other Current Liabilities135,1446.081%127,397130,154117,360139,357
Liab asso w/ Assets Held for Sale0--10,076000

224,1723.380%216,842218,249192,024194,316
Net Current Assets(23,769)-10.305%(26,500)(25,175)16,72565,857
Total Assets Less Current Liabilities85,881-0.642%86,436118,947155,572198,602
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases25,26524.488%20,29535,23445,21243,459
Other Non-current Liabilities1,5610.000%1,5612,56400

26,82622.739%21,85637,79745,21243,459
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital189,4500.000%189,450189,450189,450189,450
  Reserves(143,622)2.956%(139,499)(119,339)(88,669)(46,414)
  Others0--0000
Shareholders' Funds45,828-8.254%49,95170,111100,781143,036
Non-controlling Interests13,226-9.583%14,62811,0399,57912,108
Others0--0000

59,054-8.555%64,57981,150110,359155,144
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----08002,403595
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 25/11/2024 13:14
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -4,123,183
%Change-63.350%
EPS / (LPS)RMB -0.002
NBV Per Share (¥)RMB 0.024
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.